Heron Therapeutics reported $149.18M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
ALKERMES ALKS:US USD 290.9M 633K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Ani Pharmaceuticals ANIP:US USD 285.88M 213K
Eisai 4523:JP JPY 84.91B 7M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Esperion Therapeutics ESPR:US USD 259.49M 407K
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Insmed INSM:US USD 807.48M 366K
JAZZ PHA JAZZ:US USD 5.7B 294.18M
Omeros OMER:US USD 439.82M 125.46M
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Roche Holding ROG:VX 22.37B 6.29B
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B
Veracyte VCYT:US USD 500K 100K
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M